title: Physicians' adherence to tight control treatment strategy and combination DMARD therapy are additively important for reaching remission and maintaining working ability in early rheumatoid arthritis: a subanalysis of the FIN-RACo trial.
authors.affiliation: Department of Internal Medicine, Centre for Rheumatic Diseases, Tampere University Hospital, , Tampere, Finland.
authors.forename: Vappu
authors.initials: V
authors.lastname: Rantalaiho
authors.forename: Hannu
authors.initials: H
authors.lastname: Kautiainen
authors.forename: Markku
authors.initials: M
authors.lastname: Korpela
authors.forename: Kari
authors.initials: K
authors.lastname: Puolakka
authors.forename: Harri
authors.initials: H
authors.lastname: Blåfield
authors.forename: Kirsti
authors.initials: K
authors.lastname: Ilva
authors.forename: Pekka
authors.initials: P
authors.lastname: Hannonen
authors.forename: Marjatta
authors.initials: M
authors.lastname: Leirisalo-Repo
authors.forename: Timo
authors.initials: T
authors.lastname: Möttönen
mesh_terms: D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D016903:Drug Monitoring; D004359:Drug Therapy, Combination; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D011239:Prednisolone / Q000627:therapeutic use; D012074:Remission Induction
chemical_list: D018501:Antirheumatic Agents; D005938:Glucocorticoids; D011239:Prednisolone
keywords: DMARDs (synthetic); Early Rheumatoid Arthritis; Outcomes research; Rheumatoid Arthritis; Treatment